Costs in medicine – the lesser of two evils

Por Skrzypczyk, Michał Andrzej, Dobruch, Jakub
Publicado em 2014

Should all specimens taken during surgical treatment of patients with benign prostatic hyperplasia be assessed by a pathologist?

Por Skrzypczyk, Michał Andrzej, Dobruch, Jakub, Nyk, Łukasz, Szostek, Przemysław, Szempliński, Stanisław, Borówka, Andrzej
Publicado em 2014

Should active surveillance in prostate cancer patients be based on a single histological assessment?

Por Nyk, Łukasz, Golabek, Tomasz, Dobruch, Jakub, Skrzypczyk, Michał Andrzej, Dzik, Tomasz, Wysocki, Maciej, Chłosta, Piotr L., Borówka, Andrzej
Publicado em 2014